Preview
Severe metabolic complications of diabetes mellitus are a common cause of morbidity and death in both type I and type II disease. The distinctions between diabetic ketoacidosis and hyperosmolar nonketotic state are clearly defined, and accurate recognition is important for proper treatment. This article focuses on the practical aspects of evaluation and management of these serious diabetic complications in adults.
Additional information
Notes on contributors
J. Michael Gonzalez-Campoy
J. Michael Gonzalez-Campoy, MD, PhD R. Paul Robertson, MD Dr Gonzalez-Campoy (right) Is a fellow, division of diabetes, endocrinology, and metabolism, University of Minnesota Medical School— Minneapolis. Dr Robertson (left) Is professor of medicine and cell biology; director, division of diabetes, endocrinology, and metabolism; and director, Clinical Research Center, University of Minnesota Medical School—Minneapolis. He also holds the Pennock Chair for Diabetes Research.
R. Paul Robertson
J. Michael Gonzalez-Campoy, MD, PhD R. Paul Robertson, MD Dr Gonzalez-Campoy (right) Is a fellow, division of diabetes, endocrinology, and metabolism, University of Minnesota Medical School— Minneapolis. Dr Robertson (left) Is professor of medicine and cell biology; director, division of diabetes, endocrinology, and metabolism; and director, Clinical Research Center, University of Minnesota Medical School—Minneapolis. He also holds the Pennock Chair for Diabetes Research.